Figures computed from official regulatory filings — .
Ownershipinsiders 0.06% · institutions 51.26% · short 0.3% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for InMed Pharmaceuticals Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
InMed Pharmaceuticals Inc. operates as a pharmaceutical drug development company in the United States. The company researches and develops cannabinoid-based pharmaceuticals products. Its product candidates include INM-901 for Alzheimer's disease, INM-089 for dry age-related macular degeneration, and INM-755, a cannabinol cream. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is based in Vancouver, Canada.
Market information source · Oct 5, 2026
SEC company identity · Oct 5, 2026
Open-market timeline · full history
51 buys1 sell— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| ADAR1 Capital Management, LLCtrack record | Buy | $24.2K | SEC |
| ADAR1 Capital Management, LLCtrack record | Buy | $21.8K | SEC |
| ADAR1 Capital Management, LLCtrack record | Buy | $11K | SEC |
| ADAR1 Capital Management, LLCtrack record | Buy | $36.9K | conv 30 | SEC |
| ADAR1 Capital Management, LLCtrack record | Buy | $70.4K | conv 31 | SEC |
| ADAR1 Capital Management, LLCtrack record | Buy | $10.8K | conv 29 | SEC |
| ADAR1 Capital Management, LLCtrack record | Buy | $1.6K | conv 19 | SEC |
| Vivo Opportunity, LLCtrack record | Buy | $3.1 | conv 17 | SEC |
| Vivo Opportunity, LLCtrack record | Buy | $7.6K | conv 18 | SEC |
| Vivo Opportunity, LLCtrack record | Buy | $764.2 | conv 18 | SEC |
| Vivo Opportunity, LLCtrack record | Buy | $21.3K | conv 22 | SEC |
| Vivo Opportunity, LLCtrack record | Buy | $29.5 | conv 17 | SEC |
| Vivo Opportunity, LLCtrack record | Buy | $2.2K | conv 18 | SEC |
| Vivo Opportunity, LLCtrack record | Buy | $616.9 | conv 17 | SEC |
| Vivo Opportunity, LLCtrack record | Buy | $84.7 | conv 18 | SEC |
| Vivo Opportunity, LLCtrack record | Buy | $2.3K | conv 17 | SEC |
| Vivo Opportunity, LLCtrack record | Buy | $6.1K | conv 17 | SEC |
| Vivo Opportunity, LLCtrack record | Buy | $839.3 | conv 18 | SEC |
| Vivo Opportunity, LLCtrack record | Buy | $227.9 | conv 17 | SEC |
| Vivo Opportunity, LLCtrack record | Buy | $5.3K | conv 19 | SEC |
| Vivo Opportunity, LLCtrack record | Buy | $25.4K | conv 18 | SEC |
| Vivo Opportunity, LLCtrack record | Buy | $31.5K | conv 18 | SEC |
| Vivo Opportunity, LLCtrack record | Buy | $970.3 | conv 17 | SEC |
| Vivo Opportunity, LLCtrack record | Buy | $8K | conv 42First in 12mo | SEC |
| Vivo Opportunity, LLCtrack record | Buy | $23K | conv 18 | SEC |